Balance Sheet - Prime Medicine, Inc. (PRME)
$(Billion, Million)| Dec-25 | Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 177.68 | 190.44 | 121.67 | 293.92 | 269.62 | 53.33 | 8.65 |
| Other current assets | 3.61 | 21.44 | 21.31 | 2.70 | 0.96 | 0.07 | 0.05 |
| Total current assets | 181.29 | 211.89 | 142.98 | 296.62 | 270.58 | 53.40 | 8.70 |
| Total non-current assets | 161.44 | 85.62 | 50.88 | 63.70 | 31.28 | 1.38 | |
| Total assets | 342.73 | 297.51 | 193.85 | 360.31 | 301.86 | 54.78 | 8.70 |
| Total current liabilities | 37.45 | 37.96 | 56.42 | 26.71 | 57.98 | 19.44 | 7.31 |
| Total non-current liabilities | 184.42 | 106.40 | 4.36 | 17.33 | 4.31 | 1.87 | |
| Total liabilities | 221.87 | 144.36 | 60.78 | 44.04 | 62.30 | 21.31 | 7.31 |
| Total stockholders' equity | 120.87 | 153.15 | 133.07 | 316.27 | 239.56 | 33.47 | 1.39 |
| Common shares outstanding | 149 | 119 | 91 | 97 | 96 | 96 | 96 |
Show Quarterly Balance Sheet
Balance Sheet - Prime Medicine, Inc. (PRME)
$(Billion, Million)| Mar-26 | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 | Sep-24 | Jun-24 | Mar-24 | Dec-23 | Sep-23 | Jun-23 | Mar-23 | Dec-22 | Sep-22 | Jun-22 | Mar-22 | Dec-21 | Sep-21 | Jun-21 | Mar-21 | Dec-20 | Dec-19 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total cash and short-term investments | 135.50 | 177.68 | 208.43 | 101.75 | 144.26 | 190.44 | 175.53 | 162.87 | 210.72 | 121.67 | 165.32 | 207.62 | 249.52 | 293.92 | 146.67 | 180.60 | 211.27 | 269.62 | 299.92 | 0.00 | 53.33 | 53.33 | 0.00 |
| Accounts receivable, net | 0.12 | 0.02 | 55.00 | 1.82 | 1.65 | 5.61 | |||||||||||||||||
| Other current assets | 2.39 | 3.61 | 22.98 | 19.42 | 19.49 | 21.44 | 15.54 | 7.94 | 6.93 | 21.31 | 19.21 | 10.87 | 3.98 | 2.70 | 2.18 | 1.00 | 0.69 | 0.96 | 0.49 | 0.07 | |||
| Total current assets | 137.89 | 181.29 | 231.41 | 121.29 | 163.77 | 211.89 | 246.07 | 170.80 | 217.65 | 142.98 | 184.53 | 218.49 | 253.50 | 296.62 | 148.85 | 181.61 | 211.96 | 270.58 | 300.41 | 53.33 | 53.40 | ||
| Total non-current assets | 156.84 | 161.44 | 153.61 | 157.72 | 164.40 | 85.62 | 86.71 | 88.90 | 93.73 | 50.88 | 54.61 | 62.38 | 63.45 | 63.70 | 66.42 | 65.99 | 32.60 | 31.28 | 14.78 | -53.33 | 1.38 | ||
| Total assets | 294.73 | 342.73 | 385.01 | 279.01 | 328.16 | 297.51 | 332.78 | 259.71 | 311.38 | 193.85 | 239.15 | 280.87 | 316.95 | 360.31 | 215.27 | 247.60 | 244.55 | 301.86 | 315.19 | 54.78 | |||
| Total current liabilities | 36.29 | 37.45 | 35.02 | 34.11 | 34.29 | 37.96 | 37.88 | 20.75 | 24.44 | 56.42 | 39.37 | 28.72 | 23.87 | 26.71 | 22.22 | 23.83 | 12.89 | 57.98 | 9.54 | 19.44 | |||
| Total non-current liabilities | 181.74 | 184.42 | 188.17 | 184.04 | 186.95 | 106.40 | 105.40 | 42.37 | 43.18 | 4.36 | 5.82 | 12.04 | 14.27 | 17.33 | 20.34 | 23.03 | 2.80 | 4.31 | 4.27 | 1.87 | |||
| Total liabilities | 218.03 | 221.87 | 223.19 | 218.15 | 221.24 | 144.36 | 143.28 | 63.12 | 67.62 | 60.78 | 45.19 | 40.76 | 38.15 | 44.04 | 42.56 | 46.86 | 15.69 | 62.30 | 13.81 | 21.31 | |||
| Total stockholders' equity | 76.70 | 120.87 | 161.82 | 60.86 | 106.92 | 153.15 | 189.50 | 196.59 | 243.77 | 133.07 | 193.96 | 240.10 | 278.80 | 316.27 | 172.70 | 200.74 | 228.86 | 239.56 | 301.38 | 33.47 | 33.47 | ||
| Common shares outstanding | 177 | 149 | 161 | 129 | 131 | 119 | 120 | 119 | 104 | 97 | 92 | 90 | 89 | 97 | 97 | 96 | 96 | 96 | 96 | 96 | 96 | 96 | 96 |